Navigation Links
Hepatitis C Carries Another Risk-Cancer Of The Immune System

According to a report published in the Journal of the American Medical Association, research points to a new risk of Hepatitis C- the chance of contracting lymphoma.

The cancer of the immune system-lymphoma or non-Hodgkins lymphoma is found to be 30 percent times higher in patients with hepatitis C, and for another cancer Waldenstroms macroglobulinemia, the risk of a hepatitis C patient contracting it is 300 times higher.

More than 4 million Americans have hepatitis C, and about 26,000 new cases are diagnosed each year, according to the U.S. Centers for Disease Control and Prevention.

Lymphomas are cancers that originate in the lymphatic system, a part of the body's immune system. The two most common forms of lymphoma are Hodgkin's and non-Hodgkin's lymphoma. About 8,000 Americans develop Hodgkin's lymphoma and more than 56,000 develop non-Hodgkin's lymphoma each year, according to the Leukemia and Lymphoma Society.

Non-Hodgkin's lymphoma is cancer that originates in the lymphoid tissue that makes up the lymph nodes, spleen and other organs of the immune system, with tumors developing from white blood cells. It is more common in men than women.

Says study author Dr. Thomas Giordano, assistant professor of medicine at Baylor College of Medicine in Houston: "If I had hepatitis C, this would be one more piece of evidence that might make me consider treatment, though hepatitis C treatment can be difficult and is often unsuccessful. On the other hand, the risk of these cancers is so small; I wouldn't panic if wasn't getting treatment either. The overall risk is low.

According to Giordano ,chronic stimulation of the immune system caused by hepatitis C might be contributing to the development of certain lymphomas.

The study subjects recruited were 150,000 veterans from the Veteran Administration (Vietnam War). The scientists marked those with a diagnosis of hepatitis C, and then they matched by ag e and sex four healthy veterans for each person infected with hepatitis C. Nearly all of the veterans included in the study were male, and the average age was 52.

The researchers found that just fewer than 1,400 people included in the study developed non-Hodgkin's lymphoma and 165 developed Waldenstrom's lymphoma.

The risk of non-Hodgkin's lymphoma was 28 percent higher for those with hepatitis C, and the risk of Waldenstrom's was 276 percent higher.

While women only comprised 3 percent of the study population, Giordano believes the results would probably apply to women as well.

According to Marshall Lichtman, executive vice president for research and medical progress for the Leukemia & Lymphoma Society, the study could help scientists better understand the connection between infection and cancer. Several infectious agents the Epstein-Barr virus, HIV and bacteria called Helicobacter pylori are all associated with lymphoma.

Experts say that these organisms could cause cancer this way: Immune cells flock to the infection site, then make lots of copies of themselves to outnumber the viruses or bacteria that they want to kill. Most of the copies are normal, but a few have genetic mistakes, or mutations, that lead to cancer.

Worldwide, about one in five cancers are caused by infection. Doctors can prevent some of these cancers with vaccines, such as the hepatitis B vaccine, which can reduce the risk of liver cancer, or the new vaccine against human papillomavirus, which protects against most cervical cancers.

Giordano says that as there's no standard screening tool for lymphoma, there aren't any immediate practical implications from the findings. He said the findings may help researchers, and they may alert physicians to think of the possibility of lymphoma in their hepatitis C patients.


'"/>




Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Need for Hepatitis Booster Questioned
9. Good News for HIV Patients Also Suffering From Hepatitis C Virus
10. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
11. The Effectiveness Of Hepatitis B Vaccine Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... ... pilot study of ActiGraph’s CentrePoint Data Hub in a sample of ... of clinical-grade wearable activity and sleep monitoring solutions for the global scientific community. ...
(Date:4/28/2017)... ... ... NuevaCare, a leading home care agency based in San Mateo, California, but ... to announce information upgrades to its blog in the form of WordPress tags. The ... as home care (generally) as well as senior care and home care agency issues. ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... respiratory hospital, based in Denver, Colorado, announced an agreement to create the Jane ... continuing support of the Jane and Leonard Korman Family Foundation. The collaboration leverages ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American Brain Foundation last ... in Neurology Award (PLINA). The couple joins a prestigious list of past PLINA ... Mondale, actor Michael J. Fox and former U.S. Attorney General Janet Reno. , ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: